Phibro Animal Health Corporation (PAHC)
Is Phibro Stock Worth Retaining in Your Portfolio Now?
PAHC Animal Health business, supported by the flourishing vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.
PAHC Stock Gains From Innovation, Market Expansion Goal
Phibro Animal Health's nutritional product offerings, such as OmniGen-AF and Animate, are being increasingly used in the global dairy industry.
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are You Looking for a Top Momentum Pick? Why Phibro Animal Health (PAHC) is a Great Choice
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
PAHC vs. ABT: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Phibro (PAHC) International Revenue Performance Explored
Examine the evolution of Phibro's (PAHC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Phibro Animal Health Corporation (PAHC) Q4 2024 Earnings Call Transcript
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2024 Earnings Call Transcript August 29, 2024 9:00 AM ET Company Participants Glenn David - CFO Jack Bendheim - Chairman, President, and CEO Daniel Bendheim - Director and EVP of Corporate Strategy Conference Call Participants Michael Ryskin - Bank of America Navann Ty - BNP Paribas Operator Good morning. My name is Julianne and I will be your conference operator today.
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Phibro Q4 Earnings and Revenues Beat, Operating Margin Down
PAHC's impressive fourth-quarter fiscal 2024 results can be attributed to the Animal Health segment's robust performance.
Here's What Key Metrics Tell Us About Phibro (PAHC) Q4 Earnings
While the top- and bottom-line numbers for Phibro (PAHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Phibro Animal Health (PAHC) Beats Q4 Earnings and Revenue Estimates
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.38 per share a year ago.
